In order to understand whether the CpG Island present in the promoter of ALDH5A1 is methylated, we treated the T98G GBM cells using increasing dosage of the global hypomethylation agent 5-Azacytidine and its vehicle control (DMSO). This evidence concerns the gene ALDH5A1 and glioblastoma.